Skip to main content
. 2004 Jul 30;2:27. doi: 10.1186/1479-5876-2-27

Table 3.

Different vaccine administration routes: intradermal vs. subcutaneous lymph node uptake

Patients mDC × 106 Administration route Isotope Max uptake (%) *
R.L. (no. 7) 4 Intradermal 99mTc-HMPAO 0.95
G.D. (no. 8) 4 Intradermal 99mTc-HMPAO 1.02
R.L. (no. 7) 4 Subcutaneous 99mTc-HMPAO 0.30
G.D. (no. 8) 4 Subcutaneous 99mTc-HMPAO 0.37

UPTAKE RATIO: intradermal/subcutaneous average: 3 *Maximum uptake = maximum lymph node activity/inoculation site activity at 0 h